Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy. (Q54427296)
Jump to navigation
Jump to search
scientific article published on 11 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy. |
scientific article published on 11 May 2010 |
Statements
Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy (English)
B George
N Pati
N Gilroy
M Ratnamohan
G Huang
M Hertzberg